SENNOSIDES- sennosides tablet 
NewVue LLC

----------

Drug Facts

Active Ingredient

Sennosides

Purpose

Laxative

Keep out of Reach of Children

In case of accidental overdose, contact a doctor or Poison Control Center immediately.

Uses

For relief of occasional constipation and irregularity.

This product produces a bowel movement in 6 to 12 hours.

Warnings

Do not use laxative products for more than one week unless directed by a doctor

Ask a doctor before use if you have stomach pains, nausea, vomiting, notice a sudden change in bowel habits that continues over a period of 2 weeks.

Stop use and ask a doctor ifrectal bleeding or failure to have a bowel movement occur after use of a laxative.  These could be signs of a serious condition.

If Pregnant or breast-feedingask a health professional before use.

Directions

Take preferably at bedtime or as directed by a doctor.  

Adults and children over 12 years: 2 tablets once a day.  Maximum of 4 tablets twice a day.

Children 6 to under 12 years: 1 tablet once a day.  Maximum of 2 tablets twice a day.

Children 2 to under 6 years: 1/2 tablet once a day.  Maximum of 1 tablet twice a day.

Children under 2: consult a doctor

Inactive Ingredients

croscarmellose sodium, dibasic dicalcium phosphate, magnesium stearate, microcrystalline cellulose, and silicon dioxide.

SEN100 Label

SENNOSIDES 
sennosides tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83813-004
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
Product Characteristics
Colorbrown (Speckled various shades of brown) Scoreno score
ShapeROUND (Round) Size8mm
FlavorImprint Code CS
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83813-004-06600 in 1 BOTTLE; Type 0: Not a Combination Product04/18/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00704/18/2016
Labeler - NewVue LLC (119120572)

Revised: 4/2024
Document Id: 15f244df-adc7-49ae-e063-6294a90a2d35
Set id: 15f23c37-5b9f-d6be-e063-6394a90a0842
Version: 1
Effective Time: 20240412
 
NewVue LLC